SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-22-000041
Filing Date
2022-11-08
Accepted
2022-11-08 10:08:31
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hska-20221108.htm   iXBRL 8-K 42503
2 EX-99.1 ex99-1earningsreleaseq32022.htm EX-99.1 240487
6 LOGO heskalogoa05a.jpg GRAPHIC 45126
  Complete submission text file 0001038133-22-000041.txt   510567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20221108.xsd EX-101.SCH 1894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20221108_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20221108_pre.xml EX-101.PRE 12506
8 EXTRACTED XBRL INSTANCE DOCUMENT hska-20221108_htm.xml XML 19243
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 221367600
SIC: 2835 In Vitro & In Vivo Diagnostic Substances